Check out the main topics of the upcoming SOLACI-CACI 2021 Congress. Save the Date!
Special Session About the COVID-19 Pandemic
Managing Cardiovascular disease and Cath Lab during the COVID-19 Pandemic
Live Case Transmissions
Coronary and Structural cases performed by distinguished international and national operators.
Coronary Track
Myocardial Infarction, Left Main session, Complex Bifurcations, CTO, Diffuse disease, small vessels and more.
DES latest improvements and designs, Drug eluting balloons, ablation.
Results of Revascularization Strategies in Major Randomized clinical trials: Myths and Realities.
Antiplatelet and Pharmacologic approaches during and after PCI: Lessons learned from Randomized trials and registries.
Structural Track
TAVI Techniques, Designs, Results and Indication in low , intermediate and high risk patients.
Mitral Valve Repair and Replacement When and How.
Tricuspid Valve Repair and Replacement: When and How.
PFO and left appendage closure: When and How.
International Joint Sessions
*Partnership Session with major Interventional Cardiology Societies from USA, Europe and Asia: TCT, PCR, SCAI, C3, International Andreas Gruentzig Society, CBS, Indian Life and more.
ProEducar Fellows Course for Interventionists in Training
The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...
You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025."
The event featured international experts...
The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic.
On this occasion, we will hold a 60-minute...
In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...
Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...
Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...